S&P 500   4,299.70 (+0.59%)
DOW   33,666.34 (+0.35%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.75%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.37%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.58%)
GE   112.34 (+1.31%)
DIS   80.13 (+0.29%)
AMC   7.79 (+2.91%)
PFE   32.09 (-0.03%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
S&P 500   4,299.70 (+0.59%)
DOW   33,666.34 (+0.35%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.75%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.37%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.58%)
GE   112.34 (+1.31%)
DIS   80.13 (+0.29%)
AMC   7.79 (+2.91%)
PFE   32.09 (-0.03%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
S&P 500   4,299.70 (+0.59%)
DOW   33,666.34 (+0.35%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.75%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.37%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.58%)
GE   112.34 (+1.31%)
DIS   80.13 (+0.29%)
AMC   7.79 (+2.91%)
PFE   32.09 (-0.03%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
S&P 500   4,299.70 (+0.59%)
DOW   33,666.34 (+0.35%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.75%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.37%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.58%)
GE   112.34 (+1.31%)
DIS   80.13 (+0.29%)
AMC   7.79 (+2.91%)
PFE   32.09 (-0.03%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
OTCMKTS:CLPBY

Coloplast A/S (CLPBY) Stock Forecast, Price & News

$10.51
0.00 (0.00%)
(As of 09/27/2023 ET)
Compare
Today's Range
$10.44
$10.60
50-Day Range
$10.51
$12.52
52-Week Range
$9.58
$14.77
Volume
89,350 shs
Average Volume
51,305 shs
Market Capitalization
$22.70 billion
P/E Ratio
37.54
Dividend Yield
0.73%
Price Target
N/A

Coloplast A/S MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
-0.33mentions of Coloplast A/S in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
12.50%
From $0.32 to $0.36 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.90 out of 5 stars


CLPBY stock logo

About Coloplast A/S (OTCMKTS:CLPBY) Stock

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

CLPBY Price History

CLPBY Stock News Headlines

U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Major shareholder notification
CLPBY Coloplast A/S
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Short Volatility Alert: Coloplast
Coloplast Launches New Catheter in the U.S.
Coloplast A/S
See More Headlines
Receive CLPBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter.

CLPBY Company Calendar

Last Earnings
5/02/2019
Today
9/28/2023

Industry, Sector and Symbol

Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CLPBY
Previous Symbol
NASDAQ:CLPBY
Fax
N/A
Employees
14,700
Year Founded
1954

Profitability

Net Income
$585.21 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.76 billion
Cash Flow
$0.20 per share
Book Value
$0.48 per share

Miscellaneous

Outstanding Shares
2,160,000,000
Free Float
N/A
Market Cap
$22.70 billion
Optionable
Not Optionable
Beta
0.28

Social Links

The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Kristian Villumsen (Age 53)
    Pres & CEO
    Comp: $2.24M
  • Mr. Anders Lonning-Skovgaard (Age 51)
    Exec. VP & CFO
    Comp: $1.14M
  • Mr. Allan Rasmussen (Age 56)
    Exec. VP of Global Operations
    Comp: $1.01M
  • Mr. Nicolai Buhl Andersen (Age 54)
    Exec. VP of Innovation
    Comp: $969.63k
  • Mr. Paul Marcun (Age 56)
    Exec. VP of Growth
    Comp: $1.16M
  • Mr. Thomas Barfod (Age 53)
    Sr. Controller & Employees Representative Director
    Comp: $64.17k
  • Ellen Bjurgert
    VP of Investor Relations
  • Dennis Kaysen
    Director of Corp. Communications
  • Dorthe Ronnau (Age 57)
    Sr. VP of People & Culture
  • Mr. Alain Morvan
    Sr. VP of Sales Europe













CLPBY Stock - Frequently Asked Questions

Should I buy or sell Coloplast A/S stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Coloplast A/S in the last year. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CLPBY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLPBY, but not buy additional shares or sell existing shares.
View CLPBY analyst ratings
or view top-rated stocks.

How have CLPBY shares performed in 2023?

Coloplast A/S's stock was trading at $11.63 at the beginning of the year. Since then, CLPBY shares have decreased by 9.6% and is now trading at $10.51.
View the best growth stocks for 2023 here
.

Are investors shorting Coloplast A/S?

Coloplast A/S saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 51,600 shares, an increase of 493.1% from the August 31st total of 8,700 shares. Based on an average daily volume of 122,600 shares, the short-interest ratio is presently 0.4 days.
View Coloplast A/S's Short Interest
.

How were Coloplast A/S's earnings last quarter?

Coloplast A/S (OTCMKTS:CLPBY) posted its quarterly earnings results on Thursday, May, 2nd. The company reported $0.07 EPS for the quarter, hitting analysts' consensus estimates of $0.07. The company earned $688.45 million during the quarter. Coloplast A/S had a net margin of 21.62% and a trailing twelve-month return on equity of 69.30%.

How often does Coloplast A/S pay dividends? What is the dividend yield for Coloplast A/S?

Coloplast A/S declared a dividend on Wednesday, May 17th. Investors of record on Monday, May 22nd will be paid a dividend of $0.0475 per share on Tuesday, May 30th. This represents a yield of 1.34%. The ex-dividend date of this dividend is Friday, May 19th.
Read our dividend analysis for CLPBY
.

Is Coloplast A/S a good dividend stock?

Coloplast A/S (OTCMKTS:CLPBY) pays an annual dividend of $0.08 per share and currently has a dividend yield of 1.40%. The dividend payout ratio is 27.50%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLPBY will have a dividend payout ratio of 21.39% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CLPBY.

What is Coloplast A/S's stock symbol?

Coloplast A/S trades on the OTCMKTS under the ticker symbol "CLPBY."

How do I buy shares of Coloplast A/S?

Shares of CLPBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Coloplast A/S's stock price today?

One share of CLPBY stock can currently be purchased for approximately $10.51.

How much money does Coloplast A/S make?

Coloplast A/S (OTCMKTS:CLPBY) has a market capitalization of $22.70 billion and generates $2.76 billion in revenue each year. The company earns $585.21 million in net income (profit) each year or $0.28 on an earnings per share basis.

How many employees does Coloplast A/S have?

The company employs 14,700 workers across the globe.

How can I contact Coloplast A/S?

Coloplast A/S's mailing address is HOLTEDAM 1-3, HUMLEBAEK G7, 3050. The official website for the company is www.coloplast.com. The company can be reached via phone at (454) 911-1111 or via email at dkebj@coloplast.com.

This page (OTCMKTS:CLPBY) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -